{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:18Z","timestamp":1740123078273,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Tuscany Region Research Grant","award":["DGR 1157\/2011"],"award-info":[{"award-number":["DGR 1157\/2011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11010-018-3364-2","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T03:53:00Z","timestamp":1525751580000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modification of gene expression profiling related to renin\u2013angiotensin system in an ischemia\/reperfusion rat model after T3 infusion"],"prefix":"10.1007","volume":"449","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9283-5042","authenticated-orcid":false,"given":"Laura","family":"Sabatino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Balzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kusmic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"3364_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrcardio.2012.196","volume":"10","author":"CC Lang","year":"2013","unstructured":"Lang CC, Struthers AD (2013) Targeting the renin-angiotensin-aldosterone system in heart failure. Nat Rev Cardiol 10:125\u2013134. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2012.196","journal-title":"Nat Rev Cardiol"},{"key":"3364_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.vph.2009.10.009","volume":"52","author":"ML Barreto-Chaves","year":"2010","unstructured":"Barreto-Chaves ML, Carrillo-Sepulveda MA Gomes MS, Diniz DA (2010) Carneiro-Ramos. GP. The crosstalk between thyroid hormone and the renin-angiotensin system. Vasc Pharmacol 52:166\u2013170. \n                    https:\/\/doi.org\/10.1016\/j.vph.2009.10.009","journal-title":"Vasc Pharmacol"},{"key":"3364_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10557-013-6473-x","volume":"27","author":"FM Tavares","year":"2013","unstructured":"Tavares FM, da Silva IB, Gomes DA, Barreto-Chaves MLM (2013) Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion. Cardiovasc Drugs Ther 27:393\u2013402. \n                    https:\/\/doi.org\/10.1007\/s10557-013-6473-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"3364_CR4","first-page":"1","volume-title":"Renin angiotensin system and cardiovascular disease","author":"WC Mello De","year":"2009","unstructured":"De Mello WC, Re RN (2009) Systemic versus local renin angiotensin systems. An overview. In: De Mello WC, Frohlich ED (eds) Renin angiotensin system and cardiovascular disease. Humana Press, New York, pp\u00a01\u20135"},{"key":"3364_CR5","first-page":"166","volume":"52","author":"MJ Pearch","year":"1997","unstructured":"Pearch MJ (1997) Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 52:166\u2013170","journal-title":"Physiol Rev"},{"key":"3364_CR6","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","volume":"26","author":"UM Steckelings","year":"2005","unstructured":"Steckelings UM, Kaschina E, Unger T (2005) The AT2R receptor-A matter of love and hate. Peptides 26:1401\u20131409. \n                    https:\/\/doi.org\/10.1016\/j.peptides.2005.03.010","journal-title":"Peptides"},{"key":"3364_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","volume":"120","author":"ES Jones","year":"2008","unstructured":"Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE (2008) AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Therapeut 120:292\u2013316. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2008.08.009","journal-title":"Pharmacol Therapeut"},{"key":"3364_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","volume":"465","author":"M Bader","year":"2013","unstructured":"Bader M (2013) ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin. Pflugers Arch 465:79\u201385. \n                    https:\/\/doi.org\/10.1007\/s00424-012-1120-0","journal-title":"Pflugers Arch"},{"key":"3364_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1517\/13543784.2012.664131","volume":"21","author":"UM Steckelings","year":"2012","unstructured":"Steckelings UM, Unger T (2012) Angiotensin II type 2 receptor agonists where should they be applied? Expert Opin Investig Drugs 21:763\u2013766. \n                    https:\/\/doi.org\/10.1517\/13543784.2012.664131","journal-title":"Expert Opin Investig Drugs"},{"key":"3364_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1024\/0301-1526\/a000387","volume":"43","author":"L Pernomian","year":"2014","unstructured":"Pernomian L, Pernomian L, Baraldi C, Restini A (2014) Counter-regulatory effects played by the ACE-Ang II-AT1 and ACE2-Ang-(1\u20137)-Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications. Vasa 43:404\u2013414. \n                    https:\/\/doi.org\/10.1024\/0301-1526\/a000387","journal-title":"Vasa"},{"key":"3364_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","volume":"79","author":"B Swynghedauw","year":"1999","unstructured":"Swynghedauw B (1999) Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215\u2013262","journal-title":"Physiol Rev"},{"key":"3364_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00005344-200009000-00015","volume":"36","author":"C Pantos","year":"2000","unstructured":"Pantos C, Mourouzis IS, Tzeis SM, Malliopoulou V, Cokkinos DD, Asimacopoulos P, Carageorgiou HC, Varonos DD, Cokkinos DV (2000) Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts. J Cardiovasc Pharmacol 36:384\u2013389","journal-title":"J Cardiovasc Pharmacol"},{"key":"3364_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10741-005-4636-y","volume":"10","author":"DL Mann","year":"2005","unstructured":"Mann DL (2005) Left ventricular size and shape: determinants of mechanical signal transduction pathways. Heart Fail Rev 10:95\u2013100. \n                    https:\/\/doi.org\/10.1007\/s10741-005-4636-y","journal-title":"Heart Fail Rev"},{"key":"3364_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ahj.2006.10.026","volume":"153","author":"S Sehgal","year":"2007","unstructured":"Sehgal S, Drazner MH (2007) Left ventricular geometry: does shape matter? Am Heart J 153:153\u2013155. \n                    https:\/\/doi.org\/10.1016\/j.ahj.2006.10.026","journal-title":"Am Heart J"},{"key":"3364_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-8703(94)90002-7","volume":"128","author":"M Yoshiyama","year":"1994","unstructured":"Yoshiyama M, Kim S, Yamagishi H, Omura T, Tani T, Yanagi S, Toda I, Teragaki M, Akioka K, Takeuchi K (1994) Cardioprotective effect of the angiotensin II type I receptor antagonist TCV-116 on ischemia-reperfusion injury. Am Heart J 128:1\u20136","journal-title":"Am Heart J"},{"key":"3364_CR16","doi-asserted-by":"publisher","first-page":"H1206-H1215","DOI":"10.1152\/ajpheart.00839.2000","volume":"282","author":"Y Xu","year":"2002","unstructured":"Xu Y, Kumar D, Dyck JR, Ford WR, Clanachan AS, Lopaschuk GD, Jugdutt BI (2002) AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts. Am J Physiol Heart Circ Physiol 282:H1206-H1215. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00839.2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3364_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1530\/JME-16-0118","volume":"57","author":"L Sabatino","year":"2016","unstructured":"Sabatino L, Kusmic C, Nicolini G, Amato R, Casini G, Iervasi G, Balzan S (2016) T3 enhances Ang2 in rat aorta in myocardial I\/R: comparison with left ventricle. J Mol Endocrinol 57:139\u2013149. \n                    https:\/\/doi.org\/10.1530\/JME-16-0118","journal-title":"J Mol Endocrinol"},{"key":"3364_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1055\/s-0034-1368717","volume":"46","author":"A Saba","year":"2014","unstructured":"Saba A, Donzelli R, Colligiani D, Raffaelli A, Nannipieri M, Kusmic C, Dos Remedios CG, Simonides WS, Iervasi G, Zucchi R (2014) Quantification of thyroxine and 3,5,3\u2032-triiodo-thyronine in human and animal hearts by a novel liquid chromatography-tandem mass spectrometry method. Horm Metab Res 46:628\u2013634. \n                    https:\/\/doi.org\/10.1055\/s-0034-1368717","journal-title":"Horm Metab Res"},{"key":"3364_CR19","doi-asserted-by":"publisher","first-page":"e0151413","DOI":"10.1371\/journal.pone.0151413","volume":"11","author":"V Rajagopalan","year":"2016","unstructured":"Rajagopalan V, Zhang Y, Ojamaa K, Chen YF, Pingitore A, Pol CJ, Saunders D, Balasubramanian K, Towner RA, AM Gerdes (2016) Safe oral triiodo-L-thyronine therapy protects from post-infarct cardiac dysfunction and arrhythmias without cardiovascular adverse effects. PLoS ONE 11:e0151413","journal-title":"PLoS ONE"},{"key":"3364_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1055\/s-0034-1368717","volume":"37","author":"C Pantos","year":"2005","unstructured":"Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV (2005) Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm Metab Res 37:500\u2013504. \n                    https:\/\/doi.org\/10.1055\/s-0034-1368717","journal-title":"Horm Metab Res"},{"key":"3364_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10557-013-6473-x","volume":"27","author":"FM Tavares","year":"2013","unstructured":"Tavares FM, da Silva IB, Gomes DA, Barreto-Chaves ML (2013) Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion. Cardiovasc Drugs Ther 27:393\u2013402. \n                    https:\/\/doi.org\/10.1007\/s10557-013-6473-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"3364_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1172\/JCI115395","volume":"88","author":"EF Grady","year":"1991","unstructured":"Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE (1991) Expression of AT2 receptors in the developing rat fetus. J Clin Invest 88:921\u2013933. \n                    https:\/\/doi.org\/10.1172\/JCI115395","journal-title":"J Clin Invest"},{"key":"3364_CR23","doi-asserted-by":"publisher","first-page":"e53e59","DOI":"10.1161\/hypertensionaha.113.02426","volume":"63","author":"K Ohshima","year":"2014","unstructured":"Ohshima K, Mogi M, Nakaoka H, Iwanami J, Min L-J, Kanno H, Tsukuda K, Chisaka T, Bai H-Y, Wang X-L, Ogimoto A, Higaki J, Horiuchi M (2014) Possible role of Angiotensin-Converting-Enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1\u20137) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade. Hypertension 63:e53\u2013e59. \n                    https:\/\/doi.org\/10.1161\/hypertensionaha.113.02426","journal-title":"Hypertension"},{"key":"3364_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1358836X9800300206","volume":"3","author":"B Yang","year":"1998","unstructured":"Yang B, Li D, Phillips MI, Mehta P, Mehta JL (1998) Myocardial angiotensin II receptor expression and ischemia-infusion injury. Vasc Med 3:121\u2013130","journal-title":"Vasc Med"},{"key":"3364_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1440-1681.2004.04034.x","volume":"31","author":"CJ Lax","year":"2004","unstructured":"Lax CJ, Domenighetti AA, Pavia JM, Di Nicolantonio R, Curl CL, Morris MJ, Delbridge LMD (2004) Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium. Clin Exp Pharmacol Physiol 31:512\u2013517. \n                    https:\/\/doi.org\/10.1111\/j.1440-1681.2004.04034.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3364_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1753944715597623","volume":"9","author":"E Mendoza-Torres","year":"2015","unstructured":"Mendoza-Torres E, Oyarz\u00f9n A, Mondaca-Ruff D, Azocar A, Castro PF, Jalil JE, Chiong M, Lavandero S, Ocaranza MP (2015) ACE2 and vasoactive peptides: novel players in cardiovascular\/renal remodeling and hypertension. Ther Adv Cardiovasc Dis 9:217\u2013237. \n                    https:\/\/doi.org\/10.1177\/1753944715597623","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"3364_CR27","doi-asserted-by":"publisher","first-page":"R1473-R1480","DOI":"10.1152\/ajpregu.00269.2003","volume":"285","author":"LW Hu","year":"2003","unstructured":"Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285:R1473-R1480. \n                    https:\/\/doi.org\/10.1152\/ajpregu.00269.2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3364_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1113\/jphysiol.2007.134080","volume":"583","author":"MS Carneiro-Ramos","year":"2007","unstructured":"Carneiro-Ramos MS, Diniz GP, Almeida J, Vieira RIP, Pinheiro SVB, Santos RA, Barreto-Chaves MLM (2007) Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. J Physiol 583:213\u2013223. \n                    https:\/\/doi.org\/10.1113\/jphysiol.2007.134080","journal-title":"J Physiol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-018-3364-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3364-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3364-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T16:29:11Z","timestamp":1557419351000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-018-3364-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3364"],"URL":"https:\/\/doi.org\/10.1007\/s11010-018-3364-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}